Tag Archives: USPTO

October 2019 Update: Subject Matter Eligibility – A Closer Look

Posted on October 30, 2019 by Edward Sandor

Guest post from Edward Sandor. Warren Woessner also posted a blog about the Updated Guidance on October 21. On October 17, 2019, the USPTO published an October 2019 Patent Eligibility Guidance Update to the earlier 2019 Revised Patent Subject Matter … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , | Leave a comment

USPTO Proposes Fee Increases Across the Board

Posted on August 2, 2019 by Warren Woessner

Predictably, the USPTO has proposed increasing fees for about every piece of “paper” they receive/require. While most of the increases are in the 5-10% range for routine prep/pros matter, some of the increases are much larger. These often seem strategic, … Continue reading →

Posted in Post-Grant Issues, Post-issuance procedures, Reissue, USPTO Practice and Policy | Tagged , , , , | Leave a comment

Senate Committee Releases Outline for Section 101 Reform

Posted on April 18, 2019 by Warren Woessner

On April 18th, the Senate Judiciary Subcommittee on Intellectual Property released a “Draft Outline of Section 101 Reform” that is intended to provide the basis of legislative amendments to the requirements for patent reform. Apart from the proposal to effectively … Continue reading →

Posted in Patent Eligible Subject Matter, Patent Reform Legislation | Tagged , , , , , , | Leave a comment

Cleveland Clinic II – Why Can’t a Diagnostic Conclusion be a Practical Application of a Natural Law?

Posted on April 4, 2019 by Warren Woessner

Because the Federal Circuit says it can’t, that’s why!  In Cleveland Clinic Foundation v. True Health Diagnostics LLC, 859 F.3d 1352 (Fed. Cir. 2017), the panel held patent-ineligible claims to a method of assessing a test subject’s risk of having … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , | Leave a comment